The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.
In the present work we focus on the key function of N condensing viral RNA into ribonucleoprotein particles (RNPs) for viral assembly. Lacking high-resolution structural information, biochemical and ...
The Wyss team designed a CRISPR RNA therapy able to broadly fight influenza A virus infection and a preclinical system to ...
Researchers found that microplastics from everyday plastic tableware accumulate in human semen and, although not linked to ...